Scientists in the United States claim to have built a synthetic cell that can feed and reproduce

The team led by scientist Kate Adamala of the University of Minnesota has released the news—under an embargo—to several media outlets regarding the creation of a synthetic cell capable of feeding, growing, and replicating, which they have named Spudcell. Their work, which, according to Science News, was rejected by the journal Cell, is published on the team’s website, pending peer review.

Expert reactions

Luis Serrano - Spudcell

Luis Serrano

Head of the Biological Systems Design Group at the Center for Genomic Regulation and member of the European Molecular Biology Organization (EMBO)

Science Media Centre Spain
This is a significant breakthrough. However, it’s important to note that they use natural components—including a cocktail of 35 enzymes—and nourish the cell by fusing it with other liposomes that carry ribosomes and nutrients. The part about cell division is more “sexy.” But it’s not really a cell that’s been designed or made from compounds not found in nature. It’s more like a minimal cell, such as Craig Venter’s, than a designed cell. That said, it’s very good work.
The author has not responded to our request to declare conflicts of interest
EN

Juli Peretó - Spudcell

Juli Peretó

Professor of Biochemistry and Molecular Biology at the University of Valencia

Science Media Centre Spain

To begin with, I must say that Kate Adamala is well known in the field of synthetic biology and, with her many international initiatives, is a highly driven individual. The work they’re making public through this somewhat unorthodox channel—not through a journal, but through a preprint platform without peer review—is an achievement that, if confirmed to be accurate, is significant; it marks a turning point in the field.

We’ve already seen several such efforts. Craig Venter has already proposed several strategies for constructing artificial cells. The fundamental difference is that this approach, rather than proceeding top-down—starting with known cells like mycoplasma, which are very small, and reducing them—does the opposite: it’s a bottom-up construction, using elements taken from other cells, such as enzymes, ribosomes, and so on. It’s a complementary strategy.

The results they present strike me as quite spectacular because, with a relatively small number of components, they’ve managed to get the cells to divide. It doesn’t have much sustainability because the system isn’t capable of sustaining itself for very long, but still, it’s an important first step.

I think it’s important to highlight that they aren’t designing a cell from scratch, but rather building it from the minimal components necessary for it to exhibit the properties they describe—with all due caution, since the work, as I said, is being disseminated through non-traditional channels—but I believe it’s important to point this out.

I think it’s spectacular work within the field of synthetic biology.

The author has declared they have no conflicts of interest
EN

Manuel Porcar - Spudcell

Manuel Porcar

Head of the Biotechnology and Synthetic Biology Group at the University of Valencia (I2SysBio) and founder of the company DARWIN

Science Media Centre Spain

This is a truly spectacular breakthrough. It is not exactly an artificial cell, but rather a cell-like system with a very small genome and basic metabolic capabilities. However, the “cell” requires an external supply of many components, including ribosomes, and does not yet reproduce consistently. It will be very interesting to see if future versions of this development are more independent and can pass on their genome to their offspring more effectively.

The author has not responded to our request to declare conflicts of interest
EN

Víctor de Lorenzo - Spudcell

Víctor de Lorenzo

CSIC Research Professor at the National Center of Biotechnology

Science Media Centre Spain

I find the work technically sound and a significant technological advance, but it is by no means the creation of life in the laboratory—a claim that is clearly exaggerated. At no point is life created de novo. What is demonstrated is the ability to manually assemble, using preexisting biochemical components and cellular parts, a cell-like system that replicates some of its functions. In that sense, the study marks a milestone; but a milestone in biological engineering should not be confused with a milestone in the origin or creation of life.

The author has not responded to our request to declare conflicts of interest
EN

James Pelletier - Spudcell

James Pelletier

Head of the Microcellular Biophysics Group at the National Center for Biotechnology (CNB-CSIC)
Science Media Centre Spain
The interdisciplinary work of Kate Adamala and her colleagues is linked to several international initiatives, such as the EU Synthetic Cell Initiative, the U.S.-based Build-a-Cell community, and the SynCell Asia Initiative. What is striking is how they have integrated different established techniques into a single system. To compare synthetic cells, some important questions are: What is encoded in the genome? What is the nutrient source? And what is its functionality? Spudcell is an in vitro system that requires complex biomolecules, such as purified ribosomes, in its nutrient medium; it has limited capacity to grow and divide. In comparison, bacteria such as the minimal cell from the J. Craig Venter Institute can synthesize their own ribosomes and grow and divide exponentially. These are complementary approaches to studying the molecules of life.
The author has declared they have no conflicts of interest
EN

Ángel Raya_Spudcell

Ángel Raya Chamorro

ICREA Research Professor and Coordinator of the Regenerative Medicine Programme at the Bellvitge Biomedical Research Institute (IDIBELL), member of CIBER-BBN, Director of the Clinical Translation Programme in Regenerative Medicine in Catalonia, and Professor of Physiology at the University of Barcelona.

I am not going to comment on findings that have not undergone peer review. Publishing in the press before publishing in scientific journals is marketing, not science.

My opinion does not focus on the scientific validity of the finding, but on the communication process, which I consider deeply problematic. This team has chosen to bypass the mechanism that the scientific community has relied on since the 17th century to validate knowledge: publication in specialist journals. And whilst peer review is certainly not perfect, it is currently the only system that has proven effective at filtering out errors, biases and exaggerations before a finding becomes news.

Publishing a 190-page document on their own website and inviting the press (including high-profile outlets such as The New York Times and CNN) before any independent expert has assessed the work is not transparency; it is a well-executed marketing strategy. The serious issue is that this dynamic normalises the practice of presenting scientific results directly to the public without any filter, as if they were tweets or press releases. It is worryingly similar to the alternative realities and fake news that Trumpism has helped to legitimise: the replacement of method with headlines, and of consensus with immediacy.

Science journalists should act as the filter that protects the public from this noise. But, as this case shows, many have prioritised clicks over context. News aggregators and various AIs are certainly not going to act as that filter, so it falls to us scientists and science communicators. That is why my sole view is this: without peer review, no scientific news is worth its salt. I sincerely believe that participating in the debate on the merits of SpudCell would, paradoxically, be to grant legitimacy to the very procedure used here to circumvent it.

The author has not responded to our request to declare conflicts of interest
EN

Andrés Moya_Spudcell

Andrés Moya

Professor of Genetics at the University of Valencia and researcher of the Genomics and Health Area at the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio)

The study represents a significant advance in the construction of synthetic cells by integrating, within a single system, the processes of growth, nutrient uptake, DNA replication, gene expression and division. Rather than merely reproducing isolated cellular functions, the authors have succeeded in coordinating these activities within a functional cycle that approximates the behaviour of a minimal cell. The study constitutes a major milestone for synthetic biology and provides an experimental platform for investigating the organisational principles of life. However, it remains dependent on external components and conditions, and is therefore still far from achieving the metabolic and evolutionary autonomy of natural cells. Overall, the work represents an important step towards understanding and reconstructing the fundamental processes that characterise living systems. I consider this work an honour, not least because it cites one of my papers – from as far back as 2009, reference 12.
The author has not responded to our request to declare conflicts of interest
EN
The 5Ws +1
Publish it
FAQ
Contact